National Institute of Health 

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Application: 9/28/19

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
Application: 9/28/19

Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Application: 1/4/20

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Application: 8/4/20

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Application: 1/8/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Application: 1/8/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Application: 1/8/22

Biology of Bladder Cancer (R01 Clinical Trial Optional)
Application: 5/8/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)
Application: 5/8/22

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Application: 1/8/22

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Application: 11/21/19

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Application: 11/21/19

Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Application: 1/4/20

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Application: 1/8/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
Application: 1/8/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
Application: 1/8/22

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Application: 9/28/19

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
Application: 6/18/21

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Application: 1/8/22

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Application: 9/28/19

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Application: 7/31/20

Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed)
Application: 4/25/19

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
Application: 11/9/21

Microbial-based Cancer Therapy – Bugs as Drugs (R21 Clinical Trial Not Allowed)
Application: 5/8/22

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Application: 8/4/20

Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required)
Application: 6/28/19

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)
Application: 10/19/20

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
Application: 11/9/21

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)
Application: 5/8/22

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Application: 5/8/21

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Application: 11/21/19

Department of Defense 

Bone Marrow Failure Research Program: Idea Development Award
Application: 6/6/19

Lung Cancer Research Program: Career Development Award
Application: 8/1/19

Lung Cancer Research Program: Idea Development Award
Application: 5/15/19

Lung Cancer Research Program: Translational Research Partnership Award
Application: 5/15/19

Lung Cancer Research Program: Investigator-Initiated Translational Research Award
Application: 5/15/19

Ovarian Cancer Research Program: Clinical Development Award
Application: 4/30/19

Ovarian Cancer Research Program: Ovarian Cancer Academy – Early-Career Investigator Award
Application: 4/30/19

Peer Reviewed Cancer Research Program: Career Development Award
Application: 8/21/19

Peer Reviewed Cancer Research Program: Horizon Award
Application: 8/21/19

Peer Reviewed Cancer Research Program: Idea Award with Special Focus
Application: 5/22/19

Peer Reviewed Cancer Research Program: Impact Award
Application: 5/22/19

Peer Reviewed Cancer Research Program: Translational Team Science Award
Application: 5/22/19

Prostate Cancer Research Program: Early Investigator Research Award
Application: 6/6/19

Prostate Cancer Research Program: Physician Research Award
Application: 6/6/19

Addressing Smoking Cessation in Clinical Practice
Application: 5/9/19

National Cancer Institute 

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Application: 9/28/19

The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trial Required)
Application: 5/13/19

The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed)
Application: 5/13/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Application: 9/28/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
Application: 9/28/19

Center Disease Control and Prevention 

Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients
Application: 4/30/19

Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients
Application: 4/30/19

Technical Assistance to Increase Tobacco Cessation
Application: 5/13/19

Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients
Application: 4/30/19

Ovarian Cancer Research Program

Clinical Development Award
Application: 4/30/19

Ovarian Cancer Academy – Early-Career Investigator Award
Application: 4/30/19

Tell Every Amazing Lady About Ovarian Cancer
Application: 5/31/19

Ovarian Cancer Research Program
Application: 5/31/19

Oncology Nursing Society Foundation

Oncology Nursing Research Grants
Application: 4/30/19

Oncology Nursing Research Grants
Application: 8/15/2019

Mark Foundation for Cancer Research

Emerging Leader Awards
Application: 5/10/19

Retirement Research Foundation

Grants for Projects in Aging
Application: 5/1/20